<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://copywritersalute.com/2026/09/16/acido-bempedoico-i-nuovi-dati/</loc><news:news><news:publication><news:name>Comunicare Salute</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-09-16T11:06:40+00:00</news:publication_date><news:title>Acido bempedoico, i nuovi dati</news:title><news:keywords>diabete, colesterolo, ipercolesterolemia, ictus, infarto, colesterolo Ldl, rischio cardiovascolare, eventi cardiovascolari, vasi, LDL, terapie ipolipemizzanti, C-LDL, lipoproteine a bassa densità, PCSK9i, PCSK9, statine, acido bempedoico, ezetimibe, prediabete, Klaus G. Parhofer</news:keywords></news:news><image:image><image:loc>https://copywritersalute.com/wp-content/uploads/2026/09/acido-bempedoico-ictus-rischio-cardiovascolare-infarti-colesterolo-cattivo-ldl.jpg?w=150</image:loc></image:image></url></urlset>
